Evaluation of carotid artery plaque density performed on serial ultrasound scans could help identify patients at high risk for a heart attack or other adverse cardiovascular events, according to Austrian researchers.
Evaluation of carotid artery plaque density performed on serial ultrasound scans could help identify patients at high risk for a heart attack or other adverse cardiovascular events, according to Austrian researchers.
Physicians know that the majority of cardiovascular and cerebrovascular events occur in patients whose blood vessels are less than 70% occluded. Determining the degree of stenosis is thus insufficient to predict a patient's risk of suffering a heart attack or stroke, said lead researcher Dr. Markus Reiter of the department of angiography and interventional radiology at Medical University Vienna.
Reiter's team evaluated the complementary clinical value of computerassisted gray-scale-median (GSM) ultrasound measurements to determine carotid artery plaque density. Previous research has suggested that plaque that appears dark on ultrasound images and has a low GSM level could be unstable and thus associated with an increased risk for clinical complications. Study results strengthened this theory. According to Reiter, patients with reduced GSM levels on follow-up exams showed a significantly increased risk for a near-future adverse event compared with patients with increased GSM levels.
Reiter and colleagues enrolled 1268 asymptomatic patients at high risk of cardiovascular disease who underwent GSM measurement of their carotids. Scans showed that 574 patients had signs of carotid artery disease based on their plaque volume. Each of those patients had a second ultrasound exam six to nine months later to measure plaque changes. GSM levels in 230 of them had decreased at follow-up.
Investigators found that 85 (37%) of those patients experienced a major adverse cardiac event (MACE) such as heart attack, stroke, cardiac surgery, or other intervention within three years of the second ultrasound. In 344 patients, GSM levels increased between the baseline and follow- up exams. Ninety-two (28%) of those patients suffered a MACE. Results showed that vulnerable plaque in the carotid artery was not only an indicator of increased risk of stroke but was associated with disease progression elsewhere in the cardiovascular system.
Results appeared in the September issue of Radiology. Additional studies are needed to validate these findings. In the meantime, however, measuring GSM levels on serial ultrasound scans may be a noninvasive way to identify the presence of vulnerable plaques, according to Reiter.
-By H.A. Abella
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.